Quarterly report pursuant to Section 13 or 15(d)

Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative)

v3.8.0.1
Note 1 - The Company and Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Dec. 31, 2015
Dec. 31, 2014
Note 1 - Company And Summary Of Significant Accounting Policies Details Narrative        
Accumulated deficit $ (119,734,000)   $ (134,417,000)  
Cash and cash equivalent $ 30,000 $ 1,418,000 $ 47,000 $ 855,000
Diluted shares excluded from calcuation of EPS 1,142,281 3,410,034    
Research and development $ 225,000 $ 250,000